Table 3 Effect of total number of previous immune checkpoint inhibitor (ICI) doses and time from last ICI dose to COVID-19 diagnosis on the development of respiratory failure due to COVID-19
Total (n = 19) | Respiratory failure (n = 12) | No respiratory failure (n = 7) | p value | |
|---|---|---|---|---|
Total number of times ICI has been administered in the past, Median (min − max) | 7 (1 − 32) | 5.5 (1 − 18) | 16 (3 − 32) | 0.07a) |
Time from last dose of ICI to COVID-19 diagnosis, Median (min − max) | 144 (10 − 420) | 76 (10 − 274) | 221 (163 − 420) | 0.004a)* |